Patents

Issued Patents

Markowitz, S.; Ho, W. J.; Yuan, Y.; Jain, M.; Sabeh, M.; Ready, J.; Williams, N. Inhibitors of short-chain dehydrogenase activity for treating coronary disorders. 2022, US 11,426,420 B2.

Word, R. A.; Annavarapu, H. K.; Posner, B.; Ready, J.; Markowitz, S. Compositions and methods for modulating cervical ripening. 2019, WO 2019010482.

Markowitz, S.; Antczak, M.; Ready, J.; Zhang, Y. Preparation of thienopyridines and related compounds, their compositions and methods of modulating short-chain dehydrogenase activity. 2018, WO 2018218251.

Markowitz, S. D.; Yuan, Y.; Zhang, Y.; Ready, J.; Hu, B. Preparation of pyrazolopyrimidine and quinoxaline derivatives for modulating short-chain dehydrogenase activity. 2018. WO 2018145080.

McKnight, S. L.; Ready, J. M.; Pieper, A. A.; Wang, G.; Han, T. Neuroprotective chemicals identification using a nicotinamide phosphoribosyltransferase, and their therapeutic use. 2017, US 9645139.

Markowitz, S.; Willson, J.K.V.; Posner, B.; Ready, J.M.; Antczak, M.; Zhang, Y.; Desai, A.; Gerson, S.; Greenlee, W. Compositions and methods of modulating short-chain dehydrogenase activity. 2017. US 9,789,116 B2.

Ready, J.M.; Nijhawan, D.; Gonzales, S.S.; Theodoropoulos, P. Preparation of benzothiophenes and other compounds and methods and compositions for selective and targeted cancer therapy. 2015. WO 2015/035051 A1.

McKnight, S.L.; Pieper, A.A.; Ready, J.M.; De Brabander, J. Proneurogenic Compounds. 2015. U.S. Patent No. 9,095,572 B2.

McKnight, S.L.; Pieper, A.A.; Ready, J.M.; De Brabander, J. Proneurogenic Compounds. 2015. U.S. Patent No. 9,095,571 B2.

McKnight, S.L.; Pieper, A.A.; Ready, J.M.; De Brabander, J. Methods for Treating Parkinson’s Disease Using Pro-Neurogenic Compounds. 2014, U.S. 8,877,797.

McKnight, S.L.; Pieper, A.A.; Ready, J.M.; De Brabander, J. Methods of treating traumatic brain injury using pro-neurogenic compounds. 2014, US 8,791,149 B2.

McKnight, S.L.; Pieper, A.A.; Ready, J.M.; De Brabander, J. Methods of treating post-traumatic stress disorder using pro-neurogenic compounds. 2014, US8,748,473 B2.

McKnight, S.L.; Pieper, A.A.; Ready, J.M.; De Brabander, J. Methods for treating amyotrophic lateral sclerosis using pro-neurogenic compounds. 2014, US8735440 B2.

Schneider, J.; Hsieh, J.; Frantz, D. E.; McKnight, S. L.; Ready, J. M. Chemical inducers of neurogenesis. 2014, US 8,778,940 B2.

McKnight, S.L.; Pieper, A.A.; Ready, J.M.; De Brabander, J. Proneurogenic Compounds. 2013. U.S. Patent No. 8,604,074.

McKnight, S.L.; Pieper, A.A.; Ready, J.M.; De Brabander, J. Proneurogenic Compounds. 2013. U.S. Patent No. 8,362,277.

Schneider, J.; Hsieh, J.; Frantz, D. E.; McKnight, S. L.; Ready, J. M. Isoxazole amides, derivatives and methods of chemical induction of neurogenesis. 2012, US 8193225